Hollencrest Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.48M | Buy |
4,074
+1
| +0% | +$342 | 0.1% | 120 |
|
|
2026
Q1 | $1.43M | Hold |
4,073
| – | – | 0.05% | 131 |
|
|
2025
Q4 | $1.33M | Buy |
4,073
+61
| +2% | +$19.4K | 0.05% | 130 |
|
|
2025
Q3 | $1.13M | Buy |
4,012
+40
| +1% | +$11.6K | 0.04% | 142 |
|
|
2025
Q2 | $1.11M | Sell |
3,972
-89
| -2% | -$25.2K | 0.05% | 133 |
|
|
2025
Q1 | $1.27M | Sell |
4,061
-1
| -0% | -$295 | 0.05% | 126 |
|
|
2024
Q4 | $1.06M | Sell |
4,062
-80
| -2% | -$23.7K | 0.04% | 144 |
|
|
2024
Q3 | $1.33M | Buy |
4,142
+6
| +0.1% | +$1.96K | 0.05% | 125 |
|
|
2024
Q2 | $1.29M | Hold |
4,136
| – | – | 0.06% | 117 |
|
|
2024
Q1 | $1.18M | Hold |
4,136
| – | – | 0.05% | 131 |
|
|
2023
Q4 | $1.19M | Buy |
4,136
+105
| +3% | +$28.6K | 0.11% | 112 |
|
|
2023
Q3 | $1.08M | Hold |
4,031
| – | – | 0.12% | 104 |
|
|
2023
Q2 | $895K | Sell |
4,031
-29
| -0.7% | -$6.73K | 0.09% | 119 |
|
|
2023
Q1 | $982K | Buy |
4,060
+825
| +26% | +$203K | 0.1% | 109 |
|
|
2022
Q4 | $850K | Sell |
3,235
-15
| -0.5% | -$4.02K | 0.11% | 109 |
|
|
2022
Q3 | $733K | Buy |
3,250
+37
| +1% | +$8.97K | 0.09% | 112 |
|
|
2022
Q2 | $782K | Hold |
3,213
| – | – | 0.09% | 120 |
|
|
2022
Q1 | $777K | Hold |
3,213
| – | – | 0.07% | 146 |
|
|
2021
Q4 | $722K | Hold |
3,213
| – | – | 0.06% | 163 |
|
|
2021
Q3 | $683K | Hold |
3,213
| – | – | 0.06% | 159 |
|
|
2021
Q2 | $783K | Hold |
3,213
| – | – | 0.07% | 142 |
|
|
2021
Q1 | $800K | Sell |
3,213
-161
| -5% | -$38.4K | 0.08% | 141 |
|
|
2020
Q4 | $775K | Buy |
3,374
+50
| +2% | +$11.5K | 0.08% | 129 |
|
|
2020
Q3 | $844K | Sell |
3,324
-96
| -3% | -$23.8K | 0.1% | 114 |
|
|
2020
Q2 | $807K | Hold |
3,420
| – | – | 0.11% | 114 |
|
|
2020
Q1 | $693K | Hold |
3,420
| – | – | 0.1% | 130 |
|
|
2019
Q4 | $824K | Hold |
3,420
| – | – | 0.09% | 134 |
|
|
2019
Q3 | $661K | Hold |
3,420
| – | – | 0.08% | 142 |
|
|
2019
Q2 | $630K | Sell |
3,420
-12
| -0.3% | -$2.15K | 0.08% | 145 |
|
|
2019
Q1 | $652K | Sell |
3,432
-134
| -4% | -$25.6K | 0.09% | 140 |
|
|
2018
Q4 | $695K | Buy |
3,566
+134
| +4% | +$26.1K | 0.1% | 128 |
|
|
2018
Q3 | $652K | Sell |
3,432
-107
| -3% | -$21.1K | 0.09% | 140 |
|
|
2018
Q2 | $653K | Sell |
3,539
-394
| -10% | -$69.7K | 0.09% | 136 |
|
|
2018
Q1 | $671K | Buy |
3,933
+5
| +0.1% | +$918 | 0.09% | 134 |
|
|
2017
Q4 | $683K | Buy |
3,928
+1
| +0% | +$177 | 0.09% | 137 |
|
|
2017
Q3 | $732K | Sell |
3,927
-999
| -20% | -$177K | 0.1% | 131 |
|
|
2017
Q2 | $848K | Buy |
4,926
+1,501
| +44% | +$244K | 0.13% | 112 |
|
|
2017
Q1 | $562K | Buy |
+3,425
| New | +$569K | 0.08% | 164 |
|
|
2016
Q3 | – | Sell |
-3,478
| Closed | -$529K | – | 372 |
|
|
2016
Q2 | $529K | Buy |
+3,478
| New | +$541K | 0.08% | 180 |
|
|
2016
Q1 | – | Sell |
-1,731
| Closed | -$281K | – | 404 |
|
|
2015
Q4 | $281K | Hold |
1,731
| – | – | 0.05% | 283 |
|
|
2015
Q3 | $239K | Sell |
1,731
-1,178
| -40% | -$186K | 0.04% | 297 |
|
|
2015
Q2 | $446K | Sell |
2,909
-835
| -22% | -$134K | 0.06% | 203 |
|
|
2015
Q1 | $598K | Buy |
3,744
+69
| +2% | +$10.9K | 0.08% | 170 |
|
|
2014
Q4 | $585K | Buy |
3,675
+727
| +25% | +$113K | 0.08% | 179 |
|
|
2014
Q3 | $414K | Buy |
2,948
+48
| +2% | +$6.27K | 0.06% | 224 |
|
|
2014
Q2 | $344K | Sell |
2,900
-458
| -14% | -$53K | 0.05% | 253 |
|
|
2014
Q1 | $414K | Buy |
3,358
+282
| +9% | +$34.2K | 0.06% | 202 |
|
|
2013
Q4 | $351K | Buy |
+3,076
| New | +$350K | 0.06% | 212 |
|
Other funds holding AMGN
Hollencrest Capital Management's AMGN Position: Q2 2026 in Review
Hollencrest Capital Management increased its Amgen (AMGN) stake by 0.02% in Q2 2026, buying an estimated $342 and bringing the position to 4,074 shares worth $1.48M. The position accounts for 0.1% of the portfolio, ranked #120.
Hollencrest Capital Management first reported a position in AMGN in Q4 2013 and has held it in 48 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Hollencrest Capital Management held 4,074 shares of Amgen worth $1.48M as of Q2 2026.
- Hollencrest Capital Management bought 1 Amgen share in Q2 2026, an estimated $342.
- Amgen made up 0.1% of Hollencrest Capital Management's portfolio in Q2 2026, its #120 holding.
- Hollencrest Capital Management first reported a position in Amgen in Q4 2013 and has held it in 48 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.